Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency

Conditions:   Alpha-1 Antitrypsin Deficiency;   AATD Intervention:   Drug: INBRX-101/rhAAT-Fc Sponsor:   Inhibrx, Inc. Not yet recruiting

Source: ClinicalTrials.gov - January 24, 2019 Category: Research Source Type: clinical trials